Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease
A Phase II, Multicenter, Randomised, Double-blind, Placebo Controlled, Dose Finding Study of Subcutaneously Administered Interferon Beta-1a for Maintenance of Remission in Patients With Crohn's Disease A Phase II, Multicenter, Randomised, Double-blind, Placebo Controlled, Dose Finding Study of Subcuta ...